div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=a-multicenter-study-to-evaluate-the-safety-mjiriiumsaciradmin-a-10-1-253-htmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: A MULTICENTER STUDY TO EVALUATE THE SAFETY mjiriiumsaciradmin-A-10-1-253-6f98c75pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il End-of-treatment loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentinreader035viewer2022071414610f3e71ff44403a525e9a5ehtml5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=a-multicenter-study-to-evaluate-the-safety-mjiriiumsaciradmin-a-10-1-253-htmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: A MULTICENTER STUDY TO EVALUATE THE SAFETY mjiriiumsaciradmin-A-10-1-253-6f98c75pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il End-of-treatment loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentinreader035viewer2022071414610f3e71ff44403a525e9a5ehtml5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=a-multicenter-study-to-evaluate-the-safety-mjiriiumsaciradmin-a-10-1-253-htmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: A MULTICENTER STUDY TO EVALUATE THE SAFETY mjiriiumsaciradmin-A-10-1-253-6f98c75pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il End-of-treatment loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentinreader035viewer2022071414610f3e71ff44403a525e9a5ehtml5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=a-multicenter-study-to-evaluate-the-safety-mjiriiumsaciradmin-a-10-1-253-htmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: A MULTICENTER STUDY TO EVALUATE THE SAFETY mjiriiumsaciradmin-A-10-1-253-6f98c75pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il End-of-treatment loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentinreader035viewer2022071414610f3e71ff44403a525e9a5ehtml5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=a-multicenter-study-to-evaluate-the-safety-mjiriiumsaciradmin-a-10-1-253-htmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: A MULTICENTER STUDY TO EVALUATE THE SAFETY mjiriiumsaciradmin-A-10-1-253-6f98c75pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il End-of-treatment loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentinreader035viewer2022071414610f3e71ff44403a525e9a5ehtml5thumbnails5jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imageimg data-url=a-multicenter-study-to-evaluate-the-safety-mjiriiumsaciradmin-a-10-1-253-htmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: A MULTICENTER STUDY TO EVALUATE THE SAFETY mjiriiumsaciradmin-A-10-1-253-6f98c75pdfHeberon Plus Ribavirin for Treatment of Chronic Hepatitis C Table Il End-of-treatment loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader035vdocumentinreader035viewer2022071414610f3e71ff44403a525e9a5ehtml5thumbnails6jpg width=140 height=200 divdiv
